Delirium

Delirium
SpecialtyIntensive care medicine, Neurology, Psychiatry, Geriatrics
SymptomsAgitation, confusion, drowsiness, hallucinations, delusions, memory problems
Usual onsetAny age, but more often in people aged 65 and above
DurationDays to weeks, sometimes months
TypesHyperactive, hypoactive, mixed level of activity
CausesInconclusive
Risk factorsInfection, chronic health problems, certain medications, neurological problems, sleep deprivation, surgery
Differential diagnosisDementia
TreatmentTreating underlying cause, symptomatic management with medication
MedicationHaloperidol, risperidone, olanzapine, quetiapine

Delirium (formerly acute confusional state, an ambiguous term that is now discouraged[1]) is a specific state of acute confusion attributable to the direct physiological consequence of a medical condition, effects of a psychoactive substance, or multiple causes, which usually develops over the course of hours to days.[2][3] As a syndrome, delirium presents with disturbances in attention, awareness, and higher-order cognition. People with delirium may experience other neuropsychiatric disturbances, including changes in psychomotor activity (e.g. hyperactive, hypoactive, or mixed level of activity), disrupted sleep-wake cycle, emotional disturbances, disturbances of consciousness, or, altered state of consciousness, as well as perceptual disturbances (e.g. hallucinations and delusions), although these features are not required for diagnosis.

Diagnostically, delirium encompasses both the syndrome of acute confusion and its underlying organic process[3] known as an acute encephalopathy.[1] The cause of delirium may be either a disease process inside the brain or a process outside the brain that nonetheless affects the brain. Delirium may be the result of an underlying medical condition (e.g., infection or hypoxia), side effect of a medication, substance intoxication (e.g., opioids or hallucinogenic deliriants), substance withdrawal (e.g., alcohol or sedatives), or from multiple factors affecting one's overall health (e.g., malnutrition, pain, etc.). In contrast, the emotional and behavioral features due to primary psychiatric disorders (e.g., as in schizophrenia, bipolar disorder) do not meet the diagnostic criteria for 'delirium'.[2]

Delirium may be difficult to diagnose without first establishing a person's usual mental function or 'cognitive baseline'. Delirium can be confused with multiple psychiatric disorders or chronic organic brain syndromes because of many overlapping signs and symptoms in common with dementia, depression, psychosis, etc.[4][5] Delirium may occur in persons with existing mental illness, baseline intellectual disability, or dementia, entirely unrelated to any of these conditions.

Treatment of delirium requires identifying and managing the underlying causes, managing delirium symptoms, and reducing the risk of complications.[6] In some cases, temporary or symptomatic treatments are used to comfort the person or to facilitate other care (e.g., preventing people from pulling out a breathing tube). Antipsychotics are not supported for the treatment or prevention of delirium among those who are in hospital; however, they may be used in cases where a person has distressing experiences such as hallucinations or if the person poses a danger to themselves or others.[7][8][9][10][11] When delirium is caused by alcohol or sedative-hypnotic withdrawal, benzodiazepines are typically used as a treatment.[12] There is evidence that the risk of delirium in hospitalized people can be reduced by non-pharmacological care bundles (see Delirium § Prevention).[9] According to the text of DSM-5-TR, although delirium affects only 1–2% of the overall population, 18–35% of adults presenting to the hospital will have delirium, and delirium will occur in 29–65% of people who are hospitalized. Delirium occurs in 11–51% of older adults after surgery, in 81% of those in the ICU, and in 20–22% of individuals in nursing homes or post-acute care settings.[3] Among those requiring critical care, delirium is a risk factor for death within the next year.[3][13]

  1. ^ a b Slooter A, Otte WM, Devlin JW, Arora RC, Bleck TP, Claassen J, Duprey MS, Ely EW, Kaplan PW, Latronico N, Morandi A, Neufeld KJ, Sharshar T, MacLullich A, Stevens RD (February 2020). "Updated nomenclature of delirium and acute encephalopathy: statement of ten Societies". Intensive Care Medicine. 46 (5): 1020–1022. doi:10.1007/s00134-019-05907-4. PMC 7210231. PMID 32055887.
  2. ^ a b Wilson, Jo Ellen; Mart, Matthew F.; Cunningham, Colm; Shehabi, Yahya; Girard, Timothy D.; MacLullich, Alasdair M. J.; Slooter, Arjen J. C.; Ely, E. Wesley (2020-11-12). "Delirium". Nature Reviews. Disease Primers. 6 (1): 90. doi:10.1038/s41572-020-00223-4. ISSN 2056-676X. PMC 9012267. PMID 33184265. S2CID 226302415.
  3. ^ a b c d "Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR™)". American Psychiatric Association. Archived from the original on April 22, 2022. Retrieved April 18, 2022.
  4. ^ Gleason OC (March 2003). "Delirium". American Family Physician. 67 (5): 1027–34. PMID 12643363. Archived from the original on 2011-06-06.
  5. ^ Wilson JE, Andrews P, Ainsworth A, Roy K, Ely EW, Oldham MA (Fall 2021). "Pseudodelirium: Psychiatric Conditions to Consider on the Differential for Delirium". Journal of Neuropsychiatry and Clinical Neurosciences. 33 (4): 356–364. doi:10.1176/appi.neuropsych.20120316. PMC 8929410. PMID 34392693.
  6. ^ "SIGN 157 Delirium". www.sign.ac.uk. Archived from the original on 2022-12-06. Retrieved 2020-05-15.
  7. ^ Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825-e873. doi:10.1097/CCM.0000000000003299
  8. ^ Santos C.D., Rose M.Q. Extrapyramidal symptoms induced by treatment for delirium: A case report. Crit. Care Nurs.. 2021;41(3):50-54. doi:10.4037/ccn2021765
  9. ^ a b Siddiqi, Najma; Harrison, Jennifer K.; Clegg, Andrew; Teale, Elizabeth A.; Young, John; Taylor, James; Simpkins, Samantha A. (2016-03-11). "Interventions for preventing delirium in hospitalised non-ICU patients". The Cochrane Database of Systematic Reviews. 2016 (3): CD005563. doi:10.1002/14651858.CD005563.pub3. ISSN 1469-493X. PMC 10431752. PMID 26967259.
  10. ^ Neufeld KJ, Yue J, Robinson TN, Inouye SK, Needham DM (April 2016). "Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis". Journal of the American Geriatrics Society. 64 (4): 705–14. doi:10.1111/jgs.14076. PMC 4840067. PMID 27004732.
  11. ^ Burry L, Mehta S, Perreault MM, Luxenberg JS, Siddiqi N, Hutton B, et al. (June 2018). "Antipsychotics for treatment of delirium in hospitalised non-ICU patients". The Cochrane Database of Systematic Reviews. 2018 (6): CD005594. doi:10.1002/14651858.CD005594.pub3. PMC 6513380. PMID 29920656. Archived from the original on 2019-11-07. Retrieved 2019-11-07.
  12. ^ Attard A, Ranjith G, Taylor D (August 2008). "Delirium and its treatment". CNS Drugs. 22 (8): 631–44. doi:10.2165/00023210-200822080-00002. PMID 18601302. S2CID 94743.
  13. ^ Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE, et al. (April 2004). "Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit". JAMA. 291 (14): 1753–62. doi:10.1001/jama.291.14.1753. PMID 15082703.

© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search